25.85
price down icon1.41%   -0.3828
 
loading
전일 마감가:
$26.23
열려 있는:
$26.335
하루 거래량:
136.50K
Relative Volume:
0.16
시가총액:
$2.56B
수익:
$322.71M
순이익/손실:
$-298.33M
주가수익비율:
-6.3042
EPS:
-4.1
순현금흐름:
$-218.98M
1주 성능:
-3.04%
1개월 성능:
-7.64%
6개월 성능:
+29.24%
1년 성능:
-5.69%
1일 변동 폭
Value
$25.60
$26.55
1주일 범위
Value
$24.85
$29.20
52주 변동 폭
Value
$13.48
$36.60

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name
명칭
Zai Lab Limited Adr
Name
전화
862161632588
Name
주소
4560 JINKE ROAD, SHANGHAI
Name
직원
2,175
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
ZLAB's Discussions on Twitter

ZLAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
ZLAB 25.79 2.56B 322.71M -298.33M -218.98M -4.10
VRTX 448.10 115.74B 10.63B -479.80M -1.35B 13.33
REGN 746.52 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.04 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.65 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.86 24.49B 3.30B -501.07M 1.03B 11.54

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-14 개시 Morgan Stanley Overweight
2023-08-10 개시 Cantor Fitzgerald Overweight
2022-01-21 개시 Macquarie Outperform
2021-10-12 개시 Bernstein Mkt Perform
2020-04-28 개시 Goldman Buy
2020-04-15 개시 Guggenheim Buy
2019-07-12 개시 BofA/Merrill Buy
2019-07-05 개시 Macquarie Outperform
2019-01-29 개시 Credit Suisse Outperform
2018-11-21 개시 Jefferies Buy
2018-06-21 재개 Leerink Partners Outperform
2018-02-14 업그레이드 JP Morgan Neutral → Overweight
2017-10-16 개시 JP Morgan Neutral
2017-10-16 개시 Leerink Partners Outperform
모두보기

Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스

pulisher
Nov 20, 2024

Zai Lab Grants Share Units to Employees - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics - MSN

Nov 20, 2024
pulisher
Nov 18, 2024

Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares - BioSpace

Nov 18, 2024
pulisher
Nov 18, 2024

ZLABZai Lab Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Nov 18, 2024
pulisher
Nov 18, 2024

Zai Lab Raises $230M in Oversubscribed Public Offering of American Depositary Shares | ZLAB Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 18, 2024

FY2024 EPS Estimates for Zai Lab Increased by Analyst - Defense World

Nov 18, 2024
pulisher
Nov 17, 2024

Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume – Here’s What Happened - Defense World

Nov 17, 2024
pulisher
Nov 16, 2024

Digital Brands Group Inc (DBGI): Is It Worth A Small Bite At $0.10? - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Thermo Fisher Scientific Inc’s (TMO) Stock Is Harder To Predict Than You Think - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Selling Your MicroAlgo Inc (NASDAQ: MLGO) Stock? Here’s What You Need To Know - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Danaher Corp (DHR): An Important Analyst Insights - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Centerpoint Energy Inc (NYSE: CNP): Blank Check On Growth? - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Do Unitedhealth Group Inc (NYSE: UNH) Provide Stability And Growth? - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Major Improvements In VF Corp (VFC) Stock Need To Be Considered - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

A Stock Analysis Of Fortive Corp’s (FTV) - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Dollar Tree Inc’s (DLTR) Stock Is Harder To Predict Than You Think - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register

Nov 16, 2024
pulisher
Nov 16, 2024

Leerink Partnrs Increases Earnings Estimates for Zai Lab - Defense World

Nov 16, 2024
pulisher
Nov 14, 2024

Zai Lab Announces $200M Public Offering at $25.50 per ADS | ZLAB Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire

Nov 14, 2024
pulisher
Nov 13, 2024

Zai Lab Launches $200M ADS Offering with Goldman Sachs, Jefferies as Lead Managers | ZLAB Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Zai Lab Ltd (ZLAB) Reports Q3 2024 Earnings: EPS Loss of $0.04, Revenue at $101.8 Million, Slightly Misses Estimates - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

abrdn Life Sciences Investors declares $0.50 dividend - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire

Nov 12, 2024
pulisher
Nov 11, 2024

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for - GlobeNewswire

Nov 11, 2024
pulisher
Nov 11, 2024

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Business Wire

Nov 11, 2024
pulisher
Nov 10, 2024

Zai Lab (ZLAB) Scheduled to Post Quarterly Earnings on Tuesday - Defense World

Nov 10, 2024
pulisher
Nov 05, 2024

Zai Lab Limited (NASDAQ:ZLAB) Shares Sold by Mirae Asset Global Investments Co. Ltd. - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

JP Morgan analysts reiterates an Overweight rating for Roku Inc (ROKU) - Knox Daily

Nov 04, 2024
pulisher
Nov 02, 2024

Is Patterson Companies Inc (NASDAQ: PDCO) A Suitable Stock For New Investors Today? - Stocks Register

Nov 02, 2024
pulisher
Oct 29, 2024

Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China - Business Wire

Oct 29, 2024
pulisher
Oct 27, 2024

Zai Lab (NASDAQ:ZLAB) Stock Price Down 3.7% – Here’s What Happened - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Biopharma operator Zai Lab surges to 16-month high on lung cancer drug trial results - Mugglehead

Oct 25, 2024
pulisher
Oct 25, 2024

Trial highlights potential next-gen biologic for lung cancer - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

Zai Lab (NASDAQ:ZLAB) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Zai Lab (NASDAQ:ZLAB) Shares Down 3.7%What's Next? - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Hennion & Walsh Asset Management Inc. Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Zai Lab stock soars to 52-week high, touches $32.5 - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Citi raises Zai Lab target on promising trial results - Investing.com

Oct 24, 2024
pulisher
Oct 24, 2024

This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test - Investor's Business Daily

Oct 24, 2024
pulisher
Oct 24, 2024

Zai Lab (NASDAQ:ZLAB) Hits New 12-Month HighHere's What Happened - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer - BioSpace

Oct 24, 2024
pulisher
Oct 21, 2024

Zai Lab Announces Participation in November and December Investor Conferences - BioSpace

Oct 21, 2024
pulisher
Oct 21, 2024

JPMorgan Chase & Co. Raises Zai Lab (NASDAQ:ZLAB) Price Target to $44.00 - MarketBeat

Oct 21, 2024
pulisher
Oct 20, 2024

Zai Lab (NASDAQ:ZLAB) Shares Up 6.5% – Still a Buy? - Defense World

Oct 20, 2024
pulisher
Oct 18, 2024

Zai Lab (NASDAQ:ZLAB) Stock Price Up 6.5%Here's What Happened - MarketBeat

Oct 18, 2024
pulisher
Oct 17, 2024

Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 - Business Wire

Oct 17, 2024
pulisher
Oct 16, 2024

Zai Lab (NASDAQ:ZLAB) Shares Gap UpShould You Buy? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024 - BioSpace

Oct 16, 2024

Zai Lab Limited Adr (ZLAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):